Decamethonium

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Decamethonium
Decamethonium.svg
Systematic (IUPAC) name
trimethyl-(10-trimethylammoniodecyl)ammonium
Clinical data
Legal status
?
Identifiers
CAS number 156-74-1 YesY
ATC code None
PubChem CID 10921
DrugBank DB01245
ChemSpider 10459 YesY
UNII C1CG1S3T2W YesY
ChEBI CHEBI:41934 YesY
ChEMBL CHEMBL1134 YesY
Chemical data
Formula C16H38N2 + 
Mol. mass 258.486 g/mol
 YesY (what is this?)  (verify)

Decamethonium (Syncurine) is a depolarizing muscle relaxant or neuromuscular blocking agent,[1] and is used in anesthesia to induce paralysis.

Pharmacology[edit]

Decamethonium, which has a short action time, is similar to acetylcholine and acts as a partial agonist of the nicotinic acetylcholine receptor. In the motor endplate, it causes depolarization, preventing further effects to the normal release of acetylcholine from the presynaptic terminal, and therefore preventing the neural stimulus from affecting the muscle. In the process of binding, decamethonium actually activates (depolarizes) the motor endplate - but since the decamethonium itself is not degraded, the membrane remains depolarized and unresponsive to normal acetylcholine release.

Contraindications/limitations[edit]

Decamethonium does not produce unconsciousness or anesthesia, and its effects may cause considerable psychological distress while simultaneously making it impossible for a patient to communicate. For these reasons, administration of the drug to a conscious patient is strongly contraindicated, except in necessary emergency situations.

Decamethonium was used clinically in the UK for many years, but it is now available only for research purposes.

See also[edit]

References[edit]